|
|
|
|
Chromobacterium Csp_P Reduces Malaria and Dengue Infection in Vector Mosquitoes and Has Entomopathogenic and in Vitro Anti-pathogen Activities
|
|
|
|
|
|
|
|
نویسنده
|
ramirez j.l. ,short s.m. ,bahia a.c. ,saraiva r.g. ,dong y. ,kang s. ,tripathi a. ,mlambo g. ,dimopoulos g.
|
|
منبع
|
plos pathogens - 2014 - دوره : 10 - شماره : 10
|
|
چکیده
|
Plasmodium and dengue virus,the causative agents of the two most devastating vector-borne diseases,malaria and dengue,are transmitted by the two most important mosquito vectors,anopheles gambiae and aedes aegypti,respectively. insect-bacteria associations have been shown to influence vector competence for human pathogens through multi-faceted actions that include the elicitation of the insect immune system,pathogen sequestration by microbes,and bacteria-produced anti-pathogenic factors. these influences make the mosquito microbiota highly interesting from a disease control perspective. here we present a bacterium of the genus chromobacterium (csp_p),which was isolated from the midgut of field-caught aedes aegypti. csp_p can effectively colonize the mosquito midgut when introduced through an artificial nectar meal,and it also inhibits the growth of other members of the midgut microbiota. csp_p colonization of the midgut tissue activates mosquito immune responses,and csp_p exposure dramatically reduces the survival of both the larval and adult stages. ingestion of csp_p by the mosquito significantly reduces its susceptibility to plasmodium falciparum and dengue virus infection,thereby compromising the mosquito's vector competence. this bacterium also exerts in vitro anti-plasmodium and anti-dengue activities,which appear to be mediated through csp_p -produced stable bioactive factors with transmission-blocking and therapeutic potential. the anti-pathogen and entomopathogenic properties of csp_p render it a potential candidate for the development of malaria and dengue control strategies. © 2014 ramirez et al.
|
|
|
|
|
آدرس
|
w. harry feinstone department of molecular microbiology and immunology,bloomberg school of public health,johns hopkins university,baltimore,md,united states,laboratory of malaria and vector research,national institute of allergy and infectious diseases,national institutes of health,rockville,md, United States, w. harry feinstone department of molecular microbiology and immunology,bloomberg school of public health,johns hopkins university,baltimore,md, United States, w. harry feinstone department of molecular microbiology and immunology,bloomberg school of public health,johns hopkins university,baltimore,md,united states,instituto de bioquímica médica,programa de biologia molecular e biotecnologia,universidade federal do rio de janeiro,rio de janeiro, Brazil, w. harry feinstone department of molecular microbiology and immunology,bloomberg school of public health,johns hopkins university,baltimore,md, United States, w. harry feinstone department of molecular microbiology and immunology,bloomberg school of public health,johns hopkins university,baltimore,md, United States, w. harry feinstone department of molecular microbiology and immunology,bloomberg school of public health,johns hopkins university,baltimore,md, United States, w. harry feinstone department of molecular microbiology and immunology,bloomberg school of public health,johns hopkins university,baltimore,md, United States, w. harry feinstone department of molecular microbiology and immunology,bloomberg school of public health,johns hopkins university,baltimore,md, United States, w. harry feinstone department of molecular microbiology and immunology,bloomberg school of public health,johns hopkins university,baltimore,md, United States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|